FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jean Hubble

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Physiology

Genes & Molecular Sequences

Alleles

Co-author Network

Publications

TOP 3
Peter LeWitt; Danna Jennings; Kelly E Lyons; Rajesh Pahwa; Adrian L Rabinowicz; James Wang; Maria Guarnieri; Jean P Hubble; Harold Murck
Pharmacokinetic-pharmacodynamic crossover comparison of two levodopa extension strategies.
R Miller; Walter G Bradley; Merit E Cudkowicz; Jean P Hubble; Vincent Meininger; Hiroshi Mitsumoto; D Moore; H Pohlmann; D Sauer; Vincenzo Silani; M Strong; M Swash; E Vernotica
Phase II/III randomized trial of TCH346 in patients with ALS.
C Warren Olanow; Anthony H V Schapira; Peter LeWitt; Karl Kieburtz; Dirk Sauer; Gianfranco Olivieri; Harald Pohlmann; Jean P Hubble
TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jean Hubble (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Peter LeWitt; Danna Jennings; Kelly E Lyons; Rajesh Pahwa; Adrian L Rabinowicz; James Wang; Maria Guarnieri; Jean P Hubble; Harold Murck
Pharmacokinetic-pharmacodynamic crossover comparison of two levodopa extension strategies.
Movement disorders : official journal of the Movement Disorder Society 2009;24(9):1319-24.
2007: R Miller; Walter G Bradley; Merit E Cudkowicz; Jean P Hubble; Vincent Meininger; Hiroshi Mitsumoto; D Moore; H Pohlmann; D Sauer; Vincenzo Silani; M Strong; M Swash; E Vernotica
Phase II/III randomized trial of TCH346 in patients with ALS.
Neurology 2007;69(8):776-84.
2006: C Warren Olanow; Anthony H V Schapira; Peter LeWitt; Karl Kieburtz; Dirk Sauer; Gianfranco Olivieri; Harald Pohlmann; Jean P Hubble
TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial.
Lancet neurology 2006;5(12):1013-20.
2006: Rajesh Pahwa; Kelly E Lyons; Steven B Wilkinson; Richard K Simpson; William G Ondo; Daniel Tarsy; Thorkild Norregaard; Jean P Hubble; Donald A Smith; Robert A Hauser; Joseph Jankovic
Long-term evaluation of deep brain stimulation of the thalamus.
Journal of neurosurgery 2006;104(4):506-12.
2005: Jill L Ostrem; G A Kang; Indu Subramanian; M Guarnieri; Jean P Hubble; A L Rabinowicz; J Bronstein
The effect of entacapone on homocysteine levels in Parkinson disease.
Neurology 2005;64(8):1482.
2005: William Koller; M Guarnieri; Jean P Hubble; A L Rabinowicz; D Silver
An open-label evaluation of the tolerability and safety of Stalevo (carbidopa, levodopa and entacapone) in Parkinson's disease patients experiencing wearing-off.
Journal of neural transmission (Vienna, Austria : 1996) 2005;112(2):221-30.
2004: C Warren Olanow; Karl Kieburtz; Matthew B Stern; Ray L Watts; J William Langston; M Guarnieri; Jean P Hubble
Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease.
Archives of neurology 2004;61(10):1563-8.
2004: Robert G Holloway; Ira Shoulson; Stanley Fahn; Karl Kieburtz; Anthony E Lang; Kenneth Marek; Michael McDermott; John P Seibyl; William J Weiner; Bruno Musch; Cornelia Kamp; Mickie Welsh; Aileen Shinaman; Rajesh Pahwa; Lynn Barclay; Jean P Hubble; Peter LeWitt; Janis Miyasaki; Oksana Suchowersky; Mark Stacy; David S Russell; Blair Ford; John P Hammerstad; David Riley; David Standaert; Frederick Wooten; Stewart A Factor; Joseph Jankovic; Farah Atassi; Roger Kurlan; Michel Panisset; Ali H Rajput; Robert Rodnitzky; Clifford W Shults; Giselle Petsinger; Cheryl Waters; Ronald F Pfeiffer; Kevin Biglan; Leona Borchert; Amy Montgomery; Laura Sutherland; Carolyn Weeks; Maryan DeAngelis; Elspeth Sime; Susan Wood; Carol Pantella; Mary Harrigan; Barbara Fussell; Sandra Dillon; Barbara Alexander-Brown; Pamela Rainey; Marsha Tennis; Elke Rost-Ruffner; Diane Brown; Sharon Evans; Debra Berry; Jean Hall; Theresa Shirley; Judith Dobson; Deborah Fontaine; Brenda Pfeiffer; Alicia Brocht; Susan Bennett; Susan Daigneault; Karen Hodgeman; Carolynn O'Connell; Tori Ross; Karen Richard; Arthur Watts
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
Archives of neurology 2004;61(7):1044-53.
2004: Yi-Ju Li; Michael A Hauser; William Scott; Eden R Martin; Michael W Booze; Xue-Jun Qin; Jeffrey W Walter; Martha A Nance; Jean P Hubble; William Koller; Rajesh Pahwa; Matthew B Stern; Bradley C Hiner; Joseph Jankovic; Christopher G Goetz; Gary W Small; Frank L Mastaglia; Jonathan L Haines; Margaret Pericak-Vance; Jeffery Vance
Apolipoprotein E controls the risk and age at onset of Parkinson disease.
Neurology 2004;62(11):2005-9.
2003: Yi-Ju Li; Sofia A Oliveira; Puting Xu; Eden R Martin; Judith E Stenger; Clemens R Scherzer; Michael A Hauser; William Scott; Gary W Small; Martha A Nance; Ray L Watts; Jean P Hubble; William Koller; Rajesh Pahwa; Matthew B Stern; Bradley C Hiner; Joseph Jankovic; Christopher G Goetz; Frank L Mastaglia; Lefkos T Middleton; Allen D Roses; Ann M Saunders; Donald E Schmechel; Steven R Gullans; Jonathan L Haines; John Gilbert; Jeffery Vance; Margaret Pericak-Vance; Christine M Hulette; Kathleen A Welsh-Bohmer
Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.
Human molecular genetics 2003;12(24):3259-67.
2003: A Handforth; William G Ondo; S Tatter; G W Mathern; Richard K Simpson; F Walker; J P Sutton; Jean P Hubble; Joseph Jankovic
Vagus nerve stimulation for essential tremor: a pilot efficacy and safety trial.
Neurology 2003;61(10):1401-5.
2003: Robert A Hauser; Jean P Hubble; Daniel D Truong
Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD.
Neurology 2003;61(3):297-303.
2003: Thomas Roth; David B Rye; Leona D Borchert; Cindy Bartlett; Donald L Bliwise; Charles Cantor; Jay M Gorell; Jean P Hubble; Bruno Musch; C Warren Olanow; Charles Pollak; Matthew B Stern; Ray L Watts
Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists.
Sleep medicine 2003;4(4):275-80.
2003: Sofia A Oliveira; William Scott; Martha A Nance; Ray L Watts; Jean P Hubble; William Koller; Kelly E Lyons; Rajesh Pahwa; Matthew B Stern; Bradley C Hiner; Joseph Jankovic; William G Ondo; Fred H Allen; Burton L Scott; Christopher G Goetz; Gary W Small; Frank L Mastaglia; Jeffrey M Stajich; Fengyu Zhang; Michael W Booze; Joshua A Reaves; Lefkos T Middleton; Jonathan L Haines; Margaret Pericak-Vance; Jeffery Vance; Eden R Martin
Association study of Parkin gene polymorphisms with idiopathic Parkinson disease.
Archives of neurology 2003;60(7):975-80.
2003: Mickie Welsh; Michael P McDermott; Robert G Holloway; Sandy Plumb; Ronald F Pfeiffer; Jean P Hubble
Development and testing of the Parkinson's disease quality of life scale.
Movement disorders : official journal of the Movement Disorder Society 2003;18(6):637-45.
2003: Sofia A Oliveira; William Scott; Eden R Martin; Martha A Nance; Ray L Watts; Jean P Hubble; William Koller; Rajesh Pahwa; Matthew B Stern; Bradley C Hiner; William G Ondo; Fred H Allen; Burton L Scott; Christopher G Goetz; Gary W Small; Frank L Mastaglia; Jeffrey M Stajich; Fengyu Zhang; Michael W Booze; Michelle P Winn; Lefkos T Middleton; Jonathan L Haines; Margaret Pericak-Vance; Jeffery Vance
Parkin mutations and susceptibility alleles in late-onset Parkinson's disease.
Annals of neurology 2003;53(5):624-9.
2003: Joelle M van der Walt; Eden R Martin; William Scott; Fengyu Zhang; Martha A Nance; Ray L Watts; Jean P Hubble; Jonathan L Haines; William Koller; Kelly E Lyons; Rajesh Pahwa; Matthew B Stern; Amy Colcher; Bradley C Hiner; Joseph Jankovic; William G Ondo; Fred H Allen; Christopher G Goetz; Gary W Small; Frank L Mastaglia; Allen D Roses; Jeffrey M Stajich; Michael W Booze; Kenichiro Fujiwara; R A Gibson; Lefkos T Middleton; Burton L Scott; Margaret Pericak-Vance; Jeffery Vance
Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease.
Neurology 2003;60(7):1189-91.
2003: Joelle M van der Walt; Kristin K Nicodemus; Eden R Martin; William Scott; Martha A Nance; Ray L Watts; Jean P Hubble; Jonathan L Haines; William Koller; Kelly E Lyons; Rajesh Pahwa; Matthew B Stern; Amy Colcher; Bradley C Hiner; Joseph Jankovic; William G Ondo; Fred H Allen; Christopher G Goetz; Gary W Small; Frank L Mastaglia; Jeffrey M Stajich; Adam C McLaurin; Lefkos T Middleton; Burton L Scott; Donald E Schmechel; Margaret Pericak-Vance; Jeffery Vance
Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease.
American journal of human genetics 2003;72(4):804-11.
2002: Anita L DeStefano; Mark F Lew; Lawrence I Golbe; Margery H Mark; Alice Lazzarini; Mark Guttman; Erwin Montgomery; Cheryl H Waters; Carlos Singer; Ray L Watts; Lillian J Currie; G Frederick Wooten; Nancy E Maher; Jemma B Wilk; Kristin M Sullivan; Karen M Slater; Marie H Saint-Hilaire; Robert G Feldman; Oksana Suchowersky; Anne-Louise Lafontaine; Nancy Labelle; John H Growdon; Peter Vieregge; Peter P Pramstaller; Christine Klein; Jean P Hubble; Carson R Reider; Mark Stacy; Marcy E MacDonald; James Gusella; Richard H Myers
PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study.
American journal of human genetics 2002;70(5):1089-95.
2002: Yi-Ju Li; William Scott; Dale Hedges; Fengyu Zhang; P Craig Gaskell; Martha A Nance; Ray L Watts; Jean P Hubble; William Koller; Rajesh Pahwa; Matthew B Stern; Bradley C Hiner; Joseph Jankovic; Fred A Allen; Christopher G Goetz; Frank Mastaglia; Jeffrey M Stajich; Rachel A Gibson; Lefkos T Middleton; Ann M Saunders; Burton L Scott; Gary W Small; Kristin K Nicodemus; Allison D Reed; Donald E Schmechel; Kathleen A Welsh-Bohmer; P Michael Conneally; Allen D Roses; John Gilbert; Jeffery Vance; Jonathan L Haines; Margaret Pericak-Vance
Age at onset in two common neurodegenerative diseases is genetically controlled.
American journal of human genetics 2002;70(4):985-93.
2002: Jean P Hubble
Long-term studies of dopamine agonists.
Neurology 2002;58(4 Suppl 1):S42-50.
2002: NE Maher; Lawrence I Golbe; Alice Lazzarini; Margery H Mark; Lillian J Currie; G Frederick Wooten; Marie H Saint-Hilaire; Jemma B Wilk; Jeannine Volcjak; J E Maher; Robert G Feldman; Mark Guttman; Mark Lew; C H Waters; S Schuman; Oksana Suchowersky; Anne-Louise Lafontaine; Nancy Labelle; Peter Vieregge; P P Pramstaller; Christine Klein; Jean P Hubble; C Reider; John H Growdon; Ray L Watts; E Montgomery; K Baker; Carlos Singer; Mark Stacy; Richard H Myers
Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study.
Neurology 2002;58(1):79-84.
2001: Eden R Martin; William Scott; M A Nance; Ray L Watts; Jean P Hubble; William Koller; Kelly E Lyons; Rajesh Pahwa; Matthew B Stern; A Colcher; B C Hiner; Joseph Jankovic; William G Ondo; F H Allen; Christopher G Goetz; Gary W Small; D Masterman; F Mastaglia; N G Laing; J M Stajich; R C Ribble; M W Booze; A Rogala; M A Hauser; F Zhang; R A Gibson; L T Middleton; Allen D Roses; Jonathan L Haines; B L Scott; Margaret Pericak-Vance; Jeffery Vance
Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease.
JAMA : the journal of the American Medical Association 2001;286(18):2245-50.
2001: William Scott; M A Nance; Ray L Watts; Jean P Hubble; William Koller; Kelly E Lyons; Rajesh Pahwa; Matthew B Stern; A Colcher; B C Hiner; Joseph Jankovic; William G Ondo; F H Allen; Christopher G Goetz; Gary W Small; D Masterman; F Mastaglia; N G Laing; J M Stajich; B Slotterbeck; M W Booze; R C Ribble; Evadnie Rampersaud; Sandra G West; R A Gibson; L T Middleton; Allen D Roses; Jonathan L Haines; B L Scott; Jeffery Vance; Margaret Pericak-Vance
Complete genomic screen in Parkinson disease: evidence for multiple genes.
JAMA : the journal of the American Medical Association 2001;286(18):2239-44.
2001: Anita L DeStefano; Lawrence I Golbe; Margery H Mark; Alice Lazzarini; NE Maher; Marie H Saint-Hilaire; Robert G Feldman; Mark Guttman; Ray L Watts; Oksana Suchowersky; Anne-Louise Lafontaine; Nancy Labelle; Mark Lew; C H Waters; John H Growdon; Carlos Singer; Lillian J Currie; G Frederick Wooten; Peter Vieregge; P P Pramstaller; Christine Klein; Jean P Hubble; Mark Stacy; E Montgomery; Marcy E MacDonald; James Gusella; Richard H Myers
Genome-wide scan for Parkinson's disease: the GenePD Study.
Neurology 2001;57(6):1124-6.
2001: Jean P Hubble; P Novak
Pramipexole: a nonergot dopamine agonist as drug therapy in Parkinson's disease.
Expert review of neurotherapeutics 2001;1(1):43-51.
2000: Carson R Reider; Jean P Hubble
Test-retest reliability of an epidemiological instrument for Parkinson's disease.
Journal of clinical epidemiology 2000;53(8):863-5.
2000: Jean P Hubble; William Koller; P Atchison; A C Taylor; DR Citerone; B D Zussman; C J Friedman; N Hawker
Linear pharmacokinetic behavior of ropinirole during multiple dosing in patients with Parkinson's disease.
Journal of clinical pharmacology 2000;40(6):641-6.
2000: Jean P Hubble
Pre-clinical studies of pramipexole: clinical relevance.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2000;7 Suppl 1():15-20.
2000: Robert A Hauser; William Koller; Jean P Hubble; T Malapira; KL Busenbark; C Warren Olanow
Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
Movement disorders : official journal of the Movement Disorder Society 2000;15(3):485-9.
2000: Karl Kieburtz; Jean P Hubble
Benefits of COMT inhibitors in levodopa-treated parkinsonian patients: results of clinical trials.
Neurology 2000;55(11 Suppl 4):S42-5; discussion S46-50.
1999: William Scott; LH Yamaoka; Jeffrey M Stajich; Burton L Scott; Jeffery Vance; Allen D Roses; Margaret Pericak-Vance; Ray L Watts; Martha Nance; Jean P Hubble; William Koller; Matthew B Stern; Amy Colcher; F H Allen; Bradley C Hiner; Joseph Jankovic; William G Ondo; N G Laing; F Mastaglia; Christopher G Goetz; E Pappert; Gary W Small; D Masterman; Jonathan L Haines; T L Davies
The alpha-synuclein gene is not a major risk factor in familial Parkinson disease.
Neurogenetics 1999;2(3):191-2.
1999: Jean P Hubble
Novel drugs for Parkinson's disease.
The Medical clinics of North America 1999;83(2):525-36.
1998: Jean P Hubble
Aging and the basal ganglia.
Neurologic clinics 1998;16(3):649-57.
1998: AC Jones; Y Yamamura; Laura A Almasy; S Bohlega; B Elibol; Jean P Hubble; S Kuzuhara; M Uchida; T Yanagi; D E Weeks; TG Nygaard
Autosomal recessive juvenile parkinsonism maps to 6q25.2-q27 in four ethnic groups: detailed genetic mapping of the linked region.
American journal of human genetics 1998;63(1):80-7.
1998: Rajesh Pahwa; Kelly E Lyons; Jean P Hubble; KL Busenbark; J D Rienerth; A Pahwa; William Koller
Double-blind controlled trial of gabapentin in essential tremor.
Movement disorders : official journal of the Movement Disorder Society 1998;13(3):465-7.
1998: Kelly E Lyons; Jean P Hubble; Alexander Troster; Rajesh Pahwa; William Koller
Gender differences in Parkinson's disease.
Clinical neuropharmacology 1998;21(2):118-21.
1998: Jean P Hubble; J H Kurth; S L Glatt; M C Kurth; Gerard D Schellenberg; R E Hassanein; A Lieberman; William Koller
Gene-toxin interaction as a putative risk factor for Parkinson's disease with dementia.
Neuroepidemiology 1998;17(2):96-104.
1997: EK Miyawaki; Kelly E Lyons; Rajesh Pahwa; Alexander Troster; Jean P Hubble; D Smith; KL Busenbark; D McGuire; D Michalek; William Koller
Motor complications of chronic levodopa therapy in Parkinson's disease.
Clinical neuropharmacology 1997;20(6):523-30.
1997: Jean P Hubble; KL Busenbark; Rajesh Pahwa; Kelly E Lyons; William Koller
Clinical expression of essential tremor: effects of gender and age.
Movement disorders : official journal of the Movement Disorder Society 1997;12(6):969-72.
1997: William Koller; Rajesh Pahwa; KL Busenbark; Jean P Hubble; S Wilkinson; Anthony E Lang; Paul Tuite; E Sime; A Lazano; Robert A Hauser; T Malapira; D Smith; Daniel Tarsy; EK Miyawaki; Thorkild Norregaard; T Kormos; C Warren Olanow
High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor.
Annals of neurology 1997;42(3):292-9.
1997: Jean P Hubble; KL Busenbark; S Wilkinson; Rajesh Pahwa; George Paulson; Kelly E Lyons; William Koller
Effects of thalamic deep brain stimulation based on tremor type and diagnosis.
Movement disorders : official journal of the Movement Disorder Society 1997;12(3):337-41.
1997: Irene Hegeman Richard; Roger Kurlan; Caroline M Tanner; Stewart A Factor; Jean P Hubble; Oksana Suchowersky; C Waters
Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease. Parkinson Study Group.
Neurology 1997;48(4):1070-7.
1996: A Anouti; K Schmidt; Kelly E Lyons; Jean P Hubble; Gerard D Schellenberg; Lawrence I Golbe; Anthony E Lang; N Galvez-Jimenez; L Hershey; William Koller
Normal distribution of apolipoprotein E alleles in progressive supranuclear palsy.
Neurology 1996;46(4):1156-7.
1996: Jean P Hubble; KL Busenbark; S Wilkinson; R D Penn; Kelly E Lyons; William Koller
Deep brain stimulation for essential tremor.
Neurology 1996;46(4):1150-3.
1996: Rajesh Pahwa; Kelly E Lyons; D McGuire; R Dubinsky; Jean P Hubble; William Koller
Early morning akinesia in Parkinson's disease: effect of standard carbidopa/levodopa and sustained-release carbidopa/levodopa.
Neurology 1996;46(4):1059-62.
1996: S L Glatt; Jean P Hubble; Kelly E Lyons; Anthony M Paolo; Alexander Troster; R E Hassanein; William Koller
Risk factors for dementia in Parkinson's disease: effect of education.
Neuroepidemiology 1996;15(1):20-5.
1995: C Warren Olanow; Robert A Hauser; L Gauger; T Malapira; William Koller; Jean P Hubble; K Bushenbark; D Lilienfeld; J Esterlitz
The effect of deprenyl and levodopa on the progression of Parkinson's disease.
Annals of neurology 1995;38(5):771-7.
1995: Jean P Hubble; T Cao; J A Kjelstrom; William Koller; Blaine L Beaman
Nocardia species as an etiologic agent in Parkinson's disease: serological testing in a case-control study.
Journal of clinical microbiology 1995;33(10):2768-9.
1995: A Hurwitz; Jean P Hubble; S L Glatt; William Koller; J Pollack
Erythrocyte thiolmethyltransferase: another failed marker for Alzheimer's and Parkinson's diseases.
Neurology 1995;45(10):1903-6.
1995: Jean P Hubble; William Koller; N R Cutler; J J Sramek; Joseph H Friedman; Christopher G Goetz; A Ranhosky; D Korts; A Elvin
Pramipexole in patients with early Parkinson's disease.
Clinical neuropharmacology 1995;18(4):338-47.
1995: Anthony M Paolo; Alexander Troster; S L Glatt; Jean P Hubble; William Koller
Differentiation of the dementias of Alzheimer's and Parkinson's disease with the dementia rating scale.
Journal of geriatric psychiatry and neurology 1995;8(3):184-8.
1995: Rajesh Pahwa; KL Busenbark; E F Swanson-Hyland; R M Dubinsky; Jean P Hubble; C Gray; William Koller
Botulinum toxin treatment of essential head tremor.
Neurology 1995;45(4):822-4.
1995: Alexander Troster; Anthony M Paolo; Kelly E Lyons; S L Glatt; Jean P Hubble; William Koller
The influence of depression on cognition in Parkinson's disease: a pattern of impairment distinguishable from Alzheimer's disease.
Neurology 1995;45(4):672-6.
1995: William Koller; S L Glatt; Jean P Hubble; Anthony M Paolo; Alexander Troster; M S Handler; R Horvat; C Martin; K Schmidt; A Karst
Apolipoprotein E genotypes in Parkinson's disease with and without dementia.
Annals of neurology 1995;37(2):242-5.
1995: Jean P Hubble; William Koller
The parkinsonian personality.
Advances in neurology 1995;65():43-8.
1995: Anthony M Paolo; Alexander Troster; S L Glatt; Jean P Hubble; William Koller
Influence of demographic variables on the Dementia Rating Scale.
Journal of geriatric psychiatry and neurology 1995;8(1):38-41.
1994: Maria Hadjiconstantinou; Jean P Hubble; Trina A Wemlinger; Norton H Neff
Enhanced MPTP neurotoxicity after treatment with isoflurophate or cholinergic agonists.
The Journal of pharmacology and experimental therapeutics 1994;270(2):639-44.
1993: Jean P Hubble; R Venkatesh; R E Hassanein; C Gray; William Koller
Personality and depression in Parkinson's disease.
The Journal of nervous and mental disease 1993;181(11):657-62.
1993: Jean P Hubble; T Cao; R E Hassanein; J S Neuberger; William Koller
Risk factors for Parkinson's disease.
Neurology 1993;43(9):1693-7.
1993: Jean P Hubble; Rajesh Pahwa; D K Michalek; C Thomas; William Koller
Interactive video conferencing: a means of providing interim care to Parkinson's disease patients.
Movement disorders : official journal of the Movement Disorder Society 1993;8(3):380-2.
1993: Maria Hadjiconstantinou; Trina A Wemlinger; C P Sylvia; Jean P Hubble; Norton H Neff
Aromatic L-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors.
Journal of neurochemistry 1993;60(6):2175-80.
1993: KL Busenbark; Rajesh Pahwa; Jean P Hubble; K Hopfensperger; William Koller; K Pogrebra
Double-blind controlled study of methazolamide in the treatment of essential tremor.
Neurology 1993;43(5):1045-7.
1993: Rajesh Pahwa; KL Busenbark; S J Huber; D Michalek; Jean P Hubble; William Koller
Clinical experience with controlled-release carbidopa/levodopa in Parkinson's disease.
Neurology 1993;43(4):677-81.
1993: Jean P Hubble; William Koller; C Waters
Effects of selegiline dosing on motor fluctuations in Parkinson's disease.
Clinical neuropharmacology 1993;16(1):83-7.
1992: Jean P Hubble
Interactive video conferencing and Parkinson's disease.
Kansas medicine : the journal of the Kansas Medical Society 1992;93(12):351-2.
1992: KL Busenbark; Rajesh Pahwa; Jean P Hubble; William Koller
The effect of acetazolamide on essential tremor: an open-label trial.
Neurology 1992;42(7):1394-5.
1992: D G Malone; P L O'Boynick; D K Ziegler; Solomon Batnitzky; Jean P Hubble; F P Holladay
Osteomyelitis of the skull base.
Neurosurgery 1992;30(3):426-31.
1991: KL Busenbark; J Nash; S Nash; Jean P Hubble; William Koller
Is essential tremor benign?
Neurology 1991;41(12):1982-3.
1991: William Koller; J William Langston; Jean P Hubble; I Irwin; M Zack; Lawrence I Golbe; L Forno; J Ellenberg; L Kurland; A J Ruttenber
Does a long preclinical period occur in Parkinson's disease?
Geriatrics 1991;46 Suppl 1():8-15.
1991: William Koller; J William Langston; Jean P Hubble; I Irwin; M Zack; Lawrence I Golbe; L Forno; J Ellenberg; L Kurland; A J Ruttenber
Does a long preclinical period occur in Parkinson's disease?
Neurology 1991;41(5 Suppl 2):8-13.
1990: William Koller; Jean P Hubble
Levodopa therapy in Parkinson's disease.
Neurology 1990;40(10 Suppl 3):suppl 40-7; discussion 47-9.
1989: Jean P Hubble; KL Busenbark; William Koller
Essential tremor.
Clinical neuropharmacology 1989;12(6):453-82.